Roctavian
Product Images NDC 68135-927

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Roctavian (NDC 68135-927). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biomarin Pharmaceutical Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (8 mL Vial Label)

ROCTAVIAN (valoctocogene roxaparvovec-rvox) label showing a suspension for intravenous infusion. The label specifies a single-dose quantity with 16 x 10^13 vector genomes per 8 mL (2 x 10^13 vector genomes/mL). Manufactured by BioMarin Pharmaceutical Inc., Novato, CA, with NDC 68135-927-01. Barcode and usage instructions to discard unused portion are visible.*

FDA Label Image

Principal Display Panel (8 mL Vial Carton)

Packaging label for ROCTAVIAN, a suspension for intravenous infusion containing 16 x 10^13 vector genomes/8 mL (2 x 10^13 vector genomes/mL) of the active ingredient valoctocogene roxaparvovec-rvox. The label includes storage instructions to keep the product frozen and away from light and specifies it contains one single-dose vial. It is manufactured by BioMarin Pharmaceutical Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.